Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The global tuberculosis problem. An apparition from history?]

G Bjune1, E Heldal

  • 1Avdeling for vaksine, Statens Institutt for Folkehelse, Oslo.

Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke
|February 20, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

2022 TB programme review in Pakistan: strengthening governance, with better patient diagnosis and treatment.

IJTLD open·2024
Same author

Fluoroquinolone preventive therapy for children exposed to MDR-TB.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2022
Same author

Working with national TB programmes to End TB: The Union´s 7<sup>th</sup> edition of the 'Orange Guide´.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2020
Same author

Estimating subnational TB burden-why not strengthen and use routine recording and reporting?

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2020
Same author

Mass screening for active case finding of pulmonary tuberculosis in the Russian Federation: how to save costs.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2019
Same author

Local staff making sense of their tuberculosis data: key to quality care and ending tuberculosis.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2019

Tuberculosis (TB) treatment is effective in HIV-infected individuals, preventing disease spread in Tanzania. Strict chemotherapy is crucial to combat multi-drug resistant TB, representing a cost-effective health intervention.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Global Health

Context:

  • Tuberculosis (TB) incidence is rising globally, exacerbated by HIV co-infection, poverty, and inadequate public health infrastructure.
  • Tanzania faces a significant TB burden, with TB/HIV co-infection posing a major challenge to disease control efforts.
  • The emergence of multi-drug resistant tuberculosis (MDR-TB) necessitates stringent treatment protocols and robust public health strategies.

Purpose:

  • To evaluate the efficacy of current tuberculosis treatment regimens in HIV-co-infected patients in Tanzania.
  • To assess the impact of tuberculosis control programs on disease transmission in the context of limited resources.
  • To highlight the importance of strictly controlled chemotherapy in preventing the development of multi-resistant tuberculosis.

Summary:

Related Experiment Videos

  • Current tuberculosis treatment regimens demonstrate efficacy in HIV-co-infected patients, contributing to the prevention of increased disease transmission in Tanzania.
  • Strictly controlled chemotherapy is identified as the primary strategy to avert the emergence of multi-resistant tubercle bacilli.
  • Tuberculosis control is recognized by the World Bank as a highly cost-effective health intervention for adult populations.

Impact:

  • Effective TB treatment in HIV-infected individuals can mitigate disease spread and reduce overall public health burden.
  • International collaboration and research, supported by countries like Norway, are vital for developing sustainable TB control models in developing nations.
  • The findings underscore the urgent need for continued investment and commitment to tuberculosis control programs globally, especially in high-burden countries.